"Cholinergic Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.
| Descriptor ID |
D018680
|
| MeSH Number(s) |
D27.505.519.625.120.200 D27.505.696.577.120.200
|
| Concept/Terms |
Cholinergic Antagonists- Cholinergic Antagonists
- Antagonists, Cholinergic
- Cholinergic Antagonist
- Antagonist, Cholinergic
- Cholinergic-Blocking Agents
- Agents, Cholinergic-Blocking
- Cholinergic Blocking Agents
- Cholinolytics
- Acetylcholine Antagonists
- Antagonists, Acetylcholine
- Cholinergic Receptor Antagonists
- Antagonists, Cholinergic Receptor
- Receptor Antagonists, Cholinergic
Anticholinergic Agents- Anticholinergic Agents
- Agents, Anticholinergic
- Anticholinergics
- Anti-Cholinergics
- Anti Cholinergics
|
Below are MeSH descriptors whose meaning is more general than "Cholinergic Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Cholinergic Antagonists".
This graph shows the total number of publications written about "Cholinergic Antagonists" by people in this website by year, and whether "Cholinergic Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 2 | 2 |
| 2005 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholinergic Antagonists" by people in Profiles.
-
Inequities in Filled Overactive Bladder Medication Prescriptions in the US. JAMA Netw Open. 2023 05 01; 6(5):e2315074.
-
Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology. 2021 09; 46(10):1802-1810.
-
Scopolamine Treatment and Adaptation to Airsickness. Aerosp Med Hum Perform. 2020 Apr 01; 91(4):313-317.
-
Cognitive changes in women starting anticholinergic medications for overactive bladder: a prospective study. Int Urogynecol J. 2020 Dec; 31(12):2653-2660.
-
Anticholinergic toxicity associated with ingestion of water containing lupini bean extract. Clin Toxicol (Phila). 2017 08; 55(7):687-688.
-
Cognitive burden of anticholinergic medications in psychotic disorders. Schizophr Res. 2017 12; 190:129-135.
-
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial. J Urol. 2017 02; 197(2S):S216-S223.
-
Anticholinergic responsive cyclic myoclonus. Mov Disord. 2013 Mar; 28(3):401-2.
-
Pharmacotherapy of rhinitis and rhinosinusitis. Facial Plast Surg Clin North Am. 2012 Feb; 20(1):61-71.
-
Cholinergic signaling inhibits oxalate transport by human intestinal T84 cells. Am J Physiol Cell Physiol. 2012 Jan 01; 302(1):C46-58.